Novel Cyclooxygenase Inhibitors
The present technology provides novel compounds for treatment of rheumatoid arthritis, osteoarthritis, asthma, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, AIDS, shock,atopic dermatitis, Crohn's disease, Alzheimer's disease, cancer, familial adenomatous polyposis (FAD), glaucoma, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, ulcerative colitis and other inflammatory diseases especially in humans and the processes for the synthesis of these compounds.
Sector: Fluid systems and components for general use
Country: India
Area of Application: Inhibitors, pro-inflammatory cytokines.
Keywords: Inhibitors
Advantages: The compound shows improved cardiovascular profile. Useful in treatment of many diseases as stated above.
Environmental aspects: Not Applicable
Development Status: Laboratory Model
Legal Protection: Patent in Progress
Technical specifications:
Transfer Terms: Technology Licensing
Target Countries: India
Estimated cost (US$):
Upload any relevant document:
Contact Person: SkyQuest Technology Consulting Pvt. Ltd.
Address: 501, Krishna Complex, Opp. Devashish School, Bodakdev
City: Ahmedabad
Country: India
Zip/Pin Code: 380054
Contact Technology Provider
Technology offer
Interested in this technology?
Request further information or explore potential cooperation with the technology provider.
Technology request
Can you help meet this technology need?
Share a relevant technology, expertise or partnership opportunity with APCTT.
